所有图片(1)
别名:
N-(2,6-二甲基苯基)氯乙酰胺, 1-氯乙酰氨基-2,6-二甲苯, 2-Chloro-2′,6′-acetoxylidide, 2-氯-2′,6′-二甲基乙酰苯胺, 2-氯-N-(2,6-二甲基苯基)乙酰胺, N-(2,6-二甲基苯基)-2-氯乙酰胺, N-(2,6-二甲苯基)氯乙酰胺, N-氯乙酰基-2,6-二甲基苯胺, 氯乙酰氨基-2,6-二甲苯胺
线性分子式:
ClCH2CONHC6H3(CH3)2
CAS号:
分子量:
197.66
EC 号:
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
NACRES:
NA.24
推荐产品
等级
certified reference material
pharmaceutical secondary standard
质量水平
Agency
traceable to USP 1366080
API类
lidocaine
CofA
current certificate can be downloaded
包装
pkg of 100 mg
技术
HPLC: suitable
gas chromatography (GC): suitable
mp
150-151 °C (lit.)
应用
pharmaceutical (small molecule)
格式
neat
储存温度
2-30°C
SMILES字符串
Cc1cccc(C)c1NC(=O)CCl
InChI
1S/C10H12ClNO/c1-7-4-3-5-8(2)10(7)12-9(13)6-11/h3-5H,6H2,1-2H3,(H,12,13)
InChI key
FPQQSNUTBWFFLB-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Lidocaine Related Compound H is one of the impurities of the local anesthetic lidocaine found in bulk powder and dosage forms.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Lidocaine Related Compound H is one of the impurities of the local anesthetic lidocaine found in bulk powder and dosage forms.
应用
This pharmaceutical secondary standard can also be used as follows:
- Simultaneous estimation of lidocaine hydrochloride, tribenoside, and their related compounds in pharmaceutical formulations by high-performance liquid chromatography (HPLC) combined with a UV/Vis detector
- Multi-analysis of dexpanthenol, lidocaine hydrochloride, mepyramine maleate, and their related impurities in their combined dosage forms by high-performance liquid chromatography (HPLC)-diode array detection
- Development of an HPLC method for the estimation of three active pharmaceutical ingredients along with their impurities in a semi-solid topical formulation
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAC2078 in the slot below. This is an example certificate only and may not be the lot that you receive.
推荐产品
Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.
相关产品
产品编号
说明
价格
警示用语：
Warning
危险声明
危险分类
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Alina Plenis et al.
Chromatographia, 76(5-6), 255-265 (2013-03-14)
A new liquid chromatographic (LC) method for simultaneous determination of lidocaine hydrochloride (LH) and tribenoside (TR) along with their related compounds in pharmaceutical preparations is described. Satisfactory LC separation of all analytes after the liquid-liquid extraction (LLE) procedure with ethanol
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门